Nasdaq Stockholm AB has assessed that Cinclus Pharma Holding AB, company registration number 559136-8765, fulfills Nasdaq Stockholm’s listing requirements. Provided that Cinclus Pharma Holding AB applies for admission to trading of its shares on Nasdaq Stockholm, and that the liquidity requirements are met, first day of trading is expected to June 20, 2024.
As per today’s date the company has a total of 26,227,040 shares.
| Short Name: | CINPHA |
| ISIN Code: | SE0020388577 |
| Order book id: | 335514 |
| Maximum number of shares to be listed: | 46,537,789 |
| Clearing: | CCP Cleared |
| Segment: | Mid cap |
| Market segment: | STO Equities CCP/182 |
| Tick Size Table: | MiFID II tick size table |
| MIC: | XSTO |
ICB Classification:
| Industry code: | 20 Health Care |
| Supersector code: | 2010 Health Care |
When issued trading
Trading will be on a when issued basis from June 20 up and including June 24, 2024, i.e. trading will begin before all conditions in the offering have been fulfilled and will cease if the offering is not completed. For further information see pages 33 and 132-133 in the prospectus.
For further information concerning this exchange notice please contact Listing Qualifications, telephone +46 8 405 72 80 or iss@nasdaq.com.